Skip to content

Effect of ketamine/esketamine on postoperative delirium and cognitive dysfunctions: A systematic review and meta-analysis of randomised trials

Qianqian Guo, Xiaoyong Wei, Zhenghua Dong, Tao Wang, 博之 吉留, Na Sun, Changsheng Li

Indian Journal of Anaesthesia November 18, 2025 DOI: 10.4103/ija.ija_770_25 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Meta-analysis Randomized Peer reviewed
Topics Ketamine Esketamine
Keywords Delirium Perioperative Cognition Subgroup analysis Postoperative cognitive dysfunction Medline Anesthesia Clinical trial Intensive care medicine Randomized controlled trial Meta-analysis
Key findings Perioperative (es)ketamine significantly reduces POD risk but not POND, with esketamine excelling in delirium prevention and racemic ketamine showing better cognitive protection.

Abstract

Perioperative (es)ketamine significantly reduces POD risk but not POND. Subgroup analyses reveal esketamine excels in delirium prevention, while racemic ketamine shows better cognitive protection.

Comparable studies

Other systematic reviews and meta-analyses on esketamine, most cited first.

Study Year Design Participants
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis Adults with unipolar or bipolar major depression 2020 Systematic review and meta-analysis n = 1,877
The acute antisuicidal effects of single-dose intravenous ketamine and intranasal esketamine in individuals with major depression and bipolar disorders: A systematic review and meta-analysis. Participants in randomized controlled trials of ketamine for suicidal ideation 2020 Systematic review and meta-analysis n = 197
Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature 2021 Systematic review
Efficacy of Esketamine Augmentation in Major Depressive Disorder Patients with major depressive disorder who are treatment-resistant or acutely suicidal 2020 Systematic review and meta-analysis n = 774
Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis. Patients with treatment-resistant major depressive disorder 2025 Systematic review and meta-analysis

Citations in the library

Explore topics